News

Norma Instruments Zrt. announced that Norma Awards have been re-established to recognize outstanding performance of Norma distributors in Europe, the Asia-Pacific region, the Middle East, Latin America & the Caribbean region and Africa.

The winners were selected in a complex evaluation process and the judging criteria were defined in agreement with the sales and business development, the technical support, the product management & regulatory, and the marketing departments approved by the management of Norma Instruments Zrt.

After having examined various aspects of the above listed areas the winners of the Norma Awards 2021 are the following Norma partners by regions:

Africa Region – Sadara Medical Company, Libya

Asia-Pacific Region – Active Scientific Sdn Bhd, Malaysia

Europe Region – A. De Mori S.p.A., Italy

Latin America & the Caribbean Region – Caribbean Medical Supplies Inc., Guyana

Middle East Region – ASCO Group, Iraq

On behalf of Norma Instruments Zrt, Chief Executive Officer Gergely Domonkos Horváth and VP Business Development Dr. Csaba Hilt congratulated to the winners and thanked Norma partners for the enthusiasm, commitment and perseverance in distributing Norma products in last year’s challenging times and changing economic environment.

Norma Instruments Zrt. met the requirements of the ISO 13485:2016 certification at the latest ISO re-qualification audit.

After a highly accurate and exhaustive preparation implemented for the quality management standard for medical device manufacturers, one of the world’s leading certification companies, SGS certified Norma’s development, production and distribution processes.

The renewed ISO 13485:2016 certificate is available here.

Norma Instrument Zrt.’s bank account numbers have changed.

Our current MagNet bank accounts will be terminated to the 5th of April 2021.

Our new bank details with Sopron Bank Burgenland are the following:

BANK NAME: Sopron Bank Burgenland Zrt.

BANK ADDRESS: Budapest II. fiók, 1023 Bp., Lajos u.4-6.

SWIFT CODE: EHBBHUHS

(EUR) IBAN number

HU68 1760 0200 0095 9667 1020 0005

(USD) IBAN number

HU81 1760 0200 0095 9667 3020 0007

(HUF) 

Bank account number for HUF: 17600200-00959667-00200004

IBAN number for HUF: HU13 1760 0200 0095 9667 0020 0004

Correspondent Bank details for both accounts:

BANK NAME : Raiffeisen Bank

SWIFT CODE (for Correspondent Bank): RZBAATWW

Please, kindly use these bank details for all your future payments to Norma Instruments.

Kind regards, 

The Norma Team

The governments of Hungary and the Republic of Slovenia have implemented a joint healthcare assistance project in Kenya donating three Norma Icon-3 hematology analyzers among 44 state-of-the-art medical instruments to hospitals.

The University of Nairobi-Kenyatta National Hospital, the National Spinal Injury Referral Hospital and the Kericho County Referral Hospital will use the Norma Icon-3, a smart and small 3-diff hematology analyzer. The instruments will contribute to fight against Covid-19 and help patients to receive faster diagnosis and treatment of other diseases such as malaria or HIV.

“Together with Prime Health Pharma our local distributor in Kenya, we are a proud partner of this joint development cooperation initiative of the Hungarian and Slovenian government. Norma is committed to develop small and smart hematology analyzers that can be used in point-of-care or near-patient testing environments all over the world” – claimed Gergely Domonkos Horváth, CEO of Norma Instruments Zrt. after the donation ceremony at Kericho County Referral Hospital in Kenya.

Norma Instruments’ office will be closed for seasons holidays from December 23, 2020 to January 4, 2021

During this time, no deliveries can be dispatched and no orders can be processed.

So if your company have orders planned to be still received in 2020,
we kindly ask you to send us your firm POs
at your earliest possible convenience to make sure they can be processed on time.

Orders will be processed on a “first come, first served” principle.
Thank you, in advance for your kind consideration.

Kind regards,
The Norma Team

The newly emerged coronavirus is affecting all us now and we hope that you and your families are safe and will stay safe throughout the pandemic. Norma is dedicated to contribute and help to this still growing and sadly, worsening virus outbreak that is threatening many of our lives all around the world. For this reason, our R&D Team have introduced a new parameter in our Icon-5 and Icon-5 OP analyzers, the NLR, which is short for Neutrophil-to-Lymphocyte Ratio.

Based on multiple evaluations*, NLR was found to be the most significant factor affecting the severe illness incidence of patients who were diagnosed positive for COVID-19. These studies concluded that the age of the patient and the NLR value can be an early indication on the severity progress of the disease. This is important because it can provide a foresight to doctors who can make early estimations and preparations for the course and treatment of their patient, thus helping them to focus on the more severe cases or cases that will turn severe in the upcoming days.

It is important to note that:

• the NLR value alone is not sufficient for coronavirus screening;
• the NLR parameter alone is not capable of indicating the current status or future course of the disease of healthy or asymptomatic virus infected individuals;
• the NRL parameter alone cannot be used to give diagnosis and/or treatment and cannot by itself provide a basis for assessing or deciding on a patient’s condition.

Norma’s Point-of-Care hematology analyzers with the new NLR parameter can be an excellent tool to help doctors at the front line of the epidemic:

• CBC results can be obtained at site, thus helping them with quicker diagnosis;
• Quicker diagnosis reduces referral time, thus helping patients to receive treatment faster;
• Faster treatment leads to faster emission or transfer time, thus helping to provide a more efficient patient care.

The new NLR software is available on our website’s internal support section.

If you are interested in the new NLR parameter or our analyzers in general, please contact area sales managers for more information:
http://normadiagnostika.com/contact-us.

*References:

• Neutorphil-to-Lymphocyte Ratio Predicts Severe Illness Patients with 2019 Novel Coronavirus in the Early Stage, DOI: https://doi.org/10.1101/2020.02.10.20021584
• Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study, DOI: https://www.thelancet.com/pdfs/journals/lancet/PIIS0140-6736(20)30211-7.pdf
• Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients: https://www.thelancet.com/pdfs/journals/ebiom/PIIS2352-3964(20)30138-9.pdf